| mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.0042 |
0.9 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.9 |
| mRNA |
BRD-K88742110 |
CTRPv2 |
pan-cancer |
AAC |
-0.004 |
0.9 |
| mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
| mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.0035 |
0.9 |
| mRNA |
BMS-754807 |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |